StopAfib.org interviews Dr. Daniel Singer, of Harvard Medical School.
Find more information on this topic, Dr. Singer, and a transcript of the interview, at:
In this video interview, Dr. Singer discussed topics covered in the stroke prevention in atrial fibrillation symposium he moderated at the Boston AF Symposium 2011. The topics discussed included the RE-LY trial of dabigatran, the ROCKET AF trial of rivaroxaban, and devices for keeping clots from forming in the left atrial appendage of the heart.
Dr. Singer is a Professor of Medicine at Harvard Medical School, Professor of Epidemiology at the Harvard School of Public Health, and Chief of the Clinical Epidemiology Unit at Massachusetts General Hospital.
Leave a Reply